Additionally, CCL20 and CXCL10 play major roles in the growth, migration and metastatic capabilities of lung cancer cells and were shown to decrease immunogenicity against cancer cells through recruitment of inflammatory immune cells, leading to decreased patient survival (49, 50). Here, CXCL10 is linked to lung carcinoma.